Literature DB >> 19307953

Proton therapy for prostate cancer treatment employing online image guidance and an action level threshold.

Carlos Vargas1, Aaron Falchook, Daniel Indelicato, Anamaria Yeung, Randall Henderson, Kenneth Olivier, Sameer Keole, Christopher Williams, Zuofeng Li, Jatinder Palta.   

Abstract

PURPOSE: The ability to determine the accuracy of the final prostate position within a determined action level threshold for image-guided proton therapy is unclear.
MATERIALS AND METHODS: Three thousand one hundred ten images for 20 consecutive patients treated in 1 of our 3 proton prostate protocols from February to May of 2007 were analyzed. Daily kV images and patient repositioning were performed employing an action-level threshold (ALT) of > or = 2.5 mm for each beam. Isocentric orthogonal x-rays were obtained, and prostate position was defined via 3 gold markers for each patient in the 3 axes.
RESULTS: To achieve and confirm our action level threshold, an average of 2 x-rays sets (median 2; range, 0-4) was taken daily for each patient. Based on our ALT, we made no corrections in 8.7% (range, 0%-54%), 1 correction in 82% (41%-98%), and 2 to 3 corrections in 9% (0-27%). No patient needed 4 or more corrections. All patients were treated with a confirmed error of < 2.5 mm for every beam delivered. After all corrections, the mean and standard deviations were: anterior-posterior (z): 0.003 +/- 0.094 cm; superior-inferior (y): 0.028 +/- 0.073 cm; and right-left (x) -0.013 +/- 0.08 cm.
CONCLUSION: It is feasible to limit all final prostate positions to less than 2.5 mm employing an action level image-guided radiation therapy (IGRT) process. The residual errors after corrections were very small.

Entities:  

Mesh:

Year:  2009        PMID: 19307953     DOI: 10.1097/COC.0b013e3181841f13

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  5 in total

1.  Image-guided hypofractionated proton beam therapy for low-risk prostate cancer: Analysis of quality of life and toxicity, PCG GU 002.

Authors:  Carlos Enrique Vargas; William Fred Hartsell; Megan Dunn; Sameer Ramchandra Keole; Lucius Doh; John Chang; Gary Lynn Larson
Journal:  Rep Pract Oncol Radiother       Date:  2016-03-04

2.  Recent advances in image-guided radiotherapy for head and neck carcinoma.

Authors:  Sameer K Nath; Daniel R Simpson; Brent S Rose; Ajay P Sandhu
Journal:  J Oncol       Date:  2009-07-29       Impact factor: 4.375

3.  Morbidity dynamics in proton-photon or photon radiation therapy for locally advanced prostate cancer.

Authors:  Evgeny V Khmelevsky; Irina N Kancheli; Vladimir S Khoroshkov; Andrey D Kaprin
Journal:  Rep Pract Oncol Radiother       Date:  2017-11-24

4.  Initial toxicity, quality-of-life outcomes, and dosimetric impact in a randomized phase 3 trial of hypofractionated versus standard fractionated proton therapy for low-risk prostate cancer.

Authors:  Carlos E Vargas; Matthew Q Schmidt; Joshua R Niska; William F Hartsell; Sameer R Keole; Lucius Doh; John Han-Chih Chang; Christopher Sinesi; Rossio Rodriquez; Mark Pankuch; Gary L Larson
Journal:  Adv Radiat Oncol       Date:  2018-02-23

5.  Comparison of prostate verification with implanted gold markers in tissue surrounding the prostate and pelvic bony anatomy for external beam radiation therapy following low-dose-rate brachytherapy: a prospective clinical trial.

Authors:  Tomoya Kaneda; Toshio Ohashi; Takashi Hanada; Koji Takenaka; Shuichi Nishimura; Masanori Sakayori; Shinya Sutani; Tetsuo Momma; Naoyuki Shigematsu
Journal:  J Radiat Res       Date:  2020-09-08       Impact factor: 2.724

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.